These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12609563)

  • 41. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
    Hemminki K; Dong C
    Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden.
    Bermejo JL; Sundquist J; Hemminki K
    Int J Cancer; 2009 May; 124(9):2166-71. PubMed ID: 19117061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
    Liu H; Sundquist J; Hemminki K
    Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial clustering of ovarian and endometrial cancers.
    Hemminki K; Granström C
    Eur J Cancer; 2004 Jan; 40(1):90-5. PubMed ID: 14687794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Frank C; Sundquist J; Yu H; Hemminki A; Hemminki K
    Int J Cancer; 2017 Apr; 140(7):1510-1516. PubMed ID: 28006863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of a new primary cancer among patients with lung cancer of different histological types.
    Teppo L; Salminen E; Pukkala E
    Eur J Cancer; 2001 Mar; 37(5):613-9. PubMed ID: 11290437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Familial risk for histology-specific bone cancers: an updated study in Sweden.
    Ji J; Hemminki K
    Eur J Cancer; 2006 Sep; 42(14):2343-9. PubMed ID: 16859907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial colorectal adenocarcinoma from the Swedish Family-Cancer Database.
    Hemminki K; Li X
    Int J Cancer; 2001 Dec; 94(5):743-8. PubMed ID: 11745471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Second primary neoplasms after 19281 endocrine gland tumours: aetiological links?
    Hemminki K; Jiang Y
    Eur J Cancer; 2001 Oct; 37(15):1886-94. PubMed ID: 11576845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second primary cancers in patients with lung carcinoma.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Cancer; 1999 Jul; 86(1):186-90. PubMed ID: 10391579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parental cancer as a risk factor for brain tumors (Sweden).
    Hemminki K; Li X; Collins VP
    Cancer Causes Control; 2001 Apr; 12(3):195-9. PubMed ID: 11405324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial risks in and between stone diseases: sialolithiasis, urolithiasis and cholelithiasis in the population of Sweden.
    Hemminki K; Hemminki O; Koskinen AIM; Försti A; Sundquist K; Sundquist J; Li X
    BMC Nephrol; 2018 Jul; 19(1):158. PubMed ID: 29970034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age-specific familial risks for renal cell carcinoma with evidence on recessive heritable effects.
    Hemminki K; Li X
    Kidney Int; 2004 Jun; 65(6):2298-302. PubMed ID: 15149343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial risks in second primary breast cancer based on a family cancer database.
    Hemminki K; Vaittinen P
    Eur J Cancer; 1999 Mar; 35(3):455-8. PubMed ID: 10448299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial relationships in thyroid cancer by histo-pathological type.
    Hemminki K; Dong C
    Int J Cancer; 2000 Jan; 85(2):201-5. PubMed ID: 10629078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.